Moxifloxacin Ophthalmic Dosage

Medically reviewed by Drugs.com. Last updated on Aug 1, 2019.

• Overview
• Side Effects
• Dosage
• Professional
• Pregnancy
• More

Usual Adult Dose for Bacterial Conjunctivitis

Moxeza(R): Instill 1 drop in the affected eye(s) twice a day.
Vigamox(R): Instill 1 drop in the affected eye(s) 3 times a day.

Duration of therapy: 7 days

Use: For the treatment of bacterial conjunctivitis due to susceptible strains of:
-Moxeza(R): Aerococcus viridans, Corynebacterium macginleyi, Enterococcus faecalis, Micrococcus luteus, Staphylococcus arlettae, S aureus, S capitis, S epidermidis, S haemolyticus, S hominis, S saprophyticus, S warneri, Streptococcus mitis, S pneumoniae, S parasanguinis, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Propionibacterium acnes, Chlamydia trachomatis
-Vigamox(R): Corynebacterium species, M luteus, S aureus, S epidermidis, S haemolyticus, S hominis, S warneri, S pneumoniae, Streptococcus (viridans group), Acinetobacter lwoffii, H influenzae, H parainfluenzae, C trachomatis

Usual Pediatric Dose for Bacterial Conjunctivitis

Moxeza(R):
-Aged 4 months or older: Instill 1 drop in the affected eye(s) twice a day.

Vigamox(R): Instill 1 drop in the affected eye(s) 3 times a day.

Duration of therapy: 7 days

Use: For the treatment of bacterial conjunctivitis due to susceptible strains of:
-Moxeza(R): A viridans, C macginleyi, E faecalis, M luteus, S arlettae, S aureus, S capitis, S epidermidis, S haemolyticus, S hominis, S saprophyticus, S warneri, S mitis, S pneumoniae, S parasanguinis, E coli, H influenzae, K pneumoniae, P acnes, C trachomatis
-Vigamox(R): Corynebacterium species, M luteus, S aureus, S epidermidis, S haemolyticus, S hominis, S warneri, S pneumoniae, Streptococcus (viridans group), A lwoffii, H influenzae, H parainfluenzae, C trachomatis

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:
-Moxeza(R): None
-Vigamox(R): History of hypersensitivity to the active component, to other quinolones, or to any of the ingredients

Moxeza(R): Safety and efficacy have not been established in patients younger than 4 months.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-For topical ophthalmic use only (not for injection)
-Do not inject subconjunctivally; do not introduce directly into the anterior chamber of the eye.

Storage requirements:
-Store at 2C to 25C (36F to 77F).

Patient advice:
-Do not wear contact lenses if you have signs/symptoms of bacterial conjunctivitis.
-Avoid contaminating the applicator tip with material from the eye, fingers, or any other source; do not touch the applicator tip to any surface.
-Stop this drug and contact physician at first sign of rash or allergic reaction.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer